Skip to Main Content

Paper Details

Prediction of risk for myeloid malignancy in clonal hematopoiesis.
NEJM Evid
46
2023
CCUS, CHIP, CHRS, Clonal hematopoiesis of indeterminate, MN, clonal cytopenia of undetermined significance, cytopenia, exomes, myeloid malignancy, myeloid neoplasms, participants, patient, patients, red blood cell, variant allele
Author NameAffiliation
Abhishek NiroulaBroad Institute of MIT and Harvard University
Abhishek NiroulaLund University
Donna NeubergDana-Farber Cancer Institute
Robert Coleman LindsleyDana-Farber Cancer Institute
Robert Coleman LindsleyHarvard Medical School
Marlise R LuskinDana-Farber Cancer Institute
Marlise R LuskinHarvard Medical School
Richard M StoneDana-Farber Cancer Institute
Richard M StoneHarvard Medical School
Daniel J DeAngeloDana-Farber Cancer Institute
Daniel J DeAngeloHarvard Medical School
Caitlyn VlasschaertQueens University
Caitlyn VlasschaertQueens University
Christopher J GibsonDana-Farber Cancer Institute
Christopher J GibsonHarvard Medical School
Siddhartha JaiswalStanford University
Alexander G BickVanderbilt University
Luca MalcovatiUniversity of Pavia
Luca MalcovatiIstituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Policlinico San Matteo Foundation
Pradeep NatarajanHarvard Medical School
Pradeep NatarajanCardiovascular Research Center, Massachusetts General Hospital
Pradeep NatarajanBroad Institute of Harvard and MIT
Benjamin L EbertDana-Farber Cancer Institute
Benjamin L EbertHarvard Medical School
Benjamin L EbertCenter for Prevention of Progression, Dana-Farber Cancer Institute
Benjamin L EbertBroad Institute of MIT and Harvard University
Benjamin L EbertHoward Hughes Medical Institute
  • 1 - 27

Datasets

Release 1.2